Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE.

G Sturfelt1, O Nived, A G Sjöholm

  • 1Department of Rheumatology, University Hospital, Lund, Sweden.

Clinical and Experimental Rheumatology
|May 1, 1992
PubMed
Summary

Impaired immune complex solubilization and complement function are linked to severe systemic lupus erythematosus (SLE) disease activity. These assays may help monitor SLE progression and treatment effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment.

Lupus·2017
Same author

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Lupus·2017
Same author

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients.

Arthritis care & research·2017
Same author

Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

Lupus·2016
Same author

Breast cancer in systemic lupus.

Lupus·2016
Same author

Differences in body structure and function between patients with systemic lupus erythematosus and healthy individuals, with particular reference to joint hypermobility.

Scandinavian journal of rheumatology·2016

Area of Science:

  • Immunology
  • Rheumatology
  • Clinical Chemistry

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune complex deposition.
  • Complement system activation is implicated in SLE pathogenesis, but its precise role in disease activity and monitoring remains under investigation.

Purpose of the Study:

  • To investigate immune complex solubilization and complement function in relation to disease activity in SLE patients.
  • To assess the utility of these assays for monitoring SLE disease progression.

Main Methods:

  • Serial investigation of immune complex solubilization, haemolytic complement function, and complement proteins in 25 SLE patients.
  • Clinical assessment of disease activity using the SLEDAI (Systemic Lupus Erythematosus Disease Activity Index).

Related Experiment Videos

  • Kinetic analysis of complement pathways (classical and alternative) and C1 inhibitor complexes.

    • Main Results:

    • Decreased immune complex solubilization capacity strongly correlated with severe SLE disease activity.
    • Impaired classical pathway function was persistent in most patients, while impaired alternative pathway function was associated with severe active disease.
    • Early detection of impaired complement function preceded clinical manifestations in some patients, suggesting potential for predictive monitoring.

    Conclusions:

    • Impaired complement function, particularly the alternative pathway, is crucial in severe SLE.
    • Immune complex solubilization and complement function assays are valuable tools for monitoring SLE disease activity and guiding therapeutic interventions.